Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Open Neuropsychopharmacology Journal | journal | 0.173 Q3 | 6 | 1 | 12 | 203 | 4 | 11 | 0.33 | 203.00 | |
2 | Natural Product Reports | journal | 3.020 Q1 | 211 | 83 | 210 | 13863 | 1692 | 201 | 7.76 | 167.02 | |
3 | Advances in Molecular Toxicology | book series | 0.153 Q4 | 18 | 8 | 16 | 1244 | 6 | 14 | 0.38 | 155.50 | |
4 | Frontiers in Medicinal Chemistry | book series | 0.119 Q4 | 7 | 15 | 29 | 2233 | 3 | 28 | 0.10 | 148.87 | |
5 | Antibiotics | journal | 77 | 1 | 0 | 140 | 0 | 0 | 0.00 | 140.00 | ||
6 | Critical Reviews in Toxicology | journal | 1.546 Q1 | 129 | 43 | 114 | 5878 | 625 | 106 | 4.84 | 136.70 | |
7 | Advanced Drug Delivery Reviews | journal | 4.742 Q1 | 366 | 127 | 396 | 15651 | 5677 | 347 | 13.83 | 123.24 | |
8 | RSC Drug Discovery Series | book series | 13 | 28 | 0 | 3295 | 0 | 0 | 0.00 | 117.68 | ||
9 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.553 Q3 | 50 | 78 | 22 | 8855 | 48 | 21 | 1.13 | 113.53 | |
10 | Pharmakeftiki | journal | 0.101 Q4 | 6 | 2 | 29 | 219 | 0 | 28 | 0.00 | 109.50 | |
11 | Current Drug Metabolism | journal | 1.247 Q1 | 122 | 73 | 280 | 7949 | 1367 | 265 | 4.58 | 108.89 | |
12 | Topics in Medicinal Chemistry | book series | 0.306 Q3 | 15 | 15 | 10 | 1612 | 7 | 8 | 0.70 | 107.47 | |
13 | Expert Opinion on Emerging Drugs | journal | 0.984 Q2 | 54 | 47 | 133 | 4968 | 471 | 133 | 3.91 | 105.70 | |
14 | Progress in Medicinal Chemistry | journal | 0.769 Q2 | 38 | 6 | 27 | 624 | 45 | 21 | 1.59 | 104.00 | |
15 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 106 | 109 | 377 | 11083 | 1506 | 363 | 3.95 | 101.68 | |
16 | Open Pharmacology Journal | journal | 0.131 Q4 | 6 | 4 | 5 | 400 | 2 | 5 | 0.40 | 100.00 | |
17 | Expert Opinion on Drug Delivery | journal | 1.546 Q1 | 133 | 97 | 253 | 9623 | 1281 | 242 | 5.11 | 99.21 | |
18 | Handbook of Experimental Pharmacology | journal | 1.826 Q1 | 110 | 87 | 364 | 8617 | 1520 | 339 | 4.36 | 99.05 | |
19 | Pharmaceuticals | journal | 0.243 Q2 | 87 | 185 | 23 | 18278 | 15 | 22 | 0.65 | 98.80 | |
20 | Inflammation and Allergy - Drug Targets | journal | 1.004 Q2 | 55 | 43 | 116 | 4170 | 408 | 113 | 3.51 | 96.98 | |
21 | Neurotherapeutics | journal | 2.320 Q1 | 136 | 53 | 220 | 4993 | 1477 | 206 | 6.90 | 94.21 | |
22 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 52 | 156 | 4867 | 5 | 102 | 0.03 | 93.60 | |
23 | Toxins | journal | 0.171 Q4 | 116 | 152 | 16 | 14073 | 10 | 15 | 0.63 | 92.59 | |
24 | Cellular and Molecular Life Sciences | journal | 4.001 Q1 | 261 | 303 | 884 | 27854 | 6291 | 873 | 7.30 | 91.93 | |
25 | Toxin Reviews | journal | 0.258 Q3 | 54 | 11 | 67 | 966 | 69 | 64 | 1.08 | 87.82 | |
26 | Expert Opinion on Biological Therapy | journal | 1.256 Q1 | 102 | 147 | 477 | 12860 | 1755 | 468 | 3.73 | 87.48 | |
27 | Expert Review of Clinical Pharmacology | journal | 0.218 Q2 | 60 | 68 | 129 | 5932 | 95 | 110 | 0.74 | 87.24 | |
28 | Expert Opinion on Drug Discovery | journal | 0.548 Q2 | 84 | 90 | 330 | 7820 | 539 | 322 | 1.55 | 86.89 | |
29 | HIV Therapy | journal | 0.260 Q3 | 14 | 48 | 60 | 4159 | 25 | 42 | 0.42 | 86.65 | |
30 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.043 Q1 | 100 | 121 | 315 | 10240 | 1249 | 310 | 3.82 | 84.63 | |
31 | CNS Neuroscience and Therapeutics | journal | 1.013 Q2 | 91 | 52 | 66 | 4399 | 258 | 63 | 3.91 | 84.60 | |
32 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.531 Q2 | 30 | 27 | 79 | 2260 | 145 | 79 | 1.40 | 83.70 | |
33 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.438 Q1 | 99 | 27 | 70 | 2257 | 349 | 66 | 4.91 | 83.59 | |
34 | Expert Opinion on Therapeutic Patents | journal | 0.687 Q2 | 88 | 118 | 324 | 9662 | 668 | 316 | 2.63 | 81.88 | |
35 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
36 | Journal of International Peacekeeping | journal | 0.137 Q4 | 14 | 18 | 49 | 1393 | 13 | 46 | 0.48 | 77.39 | |
37 | Marine Drugs | journal | 0.751 Q2 | 159 | 154 | 103 | 11747 | 393 | 102 | 3.74 | 76.28 | |
38 | EPMA Journal | journal | 52 | 57 | 0 | 4343 | 0 | 0 | 0.00 | 76.19 | ||
39 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
40 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 142 | 390 | 10509 | 1531 | 333 | 3.90 | 74.01 | |
41 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 7 | 4 | 518 | 0 | 4 | 0.00 | 74.00 | ||
42 | Trends in Pharmacological Sciences | journal | 5.544 Q1 | 244 | 80 | 260 | 5902 | 3056 | 246 | 11.90 | 73.78 | |
43 | Future Medicinal Chemistry | journal | 0.476 Q2 | 90 | 140 | 120 | 10130 | 128 | 89 | 1.07 | 72.36 | |
44 | Therapeutic Delivery | journal | 63 | 70 | 0 | 5019 | 0 | 0 | 0.00 | 71.70 | ||
45 | Current Opinion in Drug Discovery and Development | journal | 1.661 Q1 | 85 | 68 | 221 | 4845 | 1124 | 204 | 5.31 | 71.25 | |
46 | Apoptosis : an international journal on programmed cell death | journal | 2.189 Q1 | 128 | 127 | 443 | 9032 | 2187 | 438 | 4.58 | 71.12 | |
47 | Current Opinion in Investigational Drugs | journal | 1.257 Q1 | 83 | 144 | 375 | 10224 | 1330 | 340 | 3.70 | 71.00 | |
48 | Current Pharmaceutical Biotechnology | journal | 1.298 Q1 | 97 | 105 | 195 | 7390 | 676 | 177 | 3.48 | 70.38 | |
49 | Expert Opinion on Pharmacotherapy | journal | 0.660 Q2 | 93 | 282 | 839 | 19205 | 2183 | 815 | 2.68 | 68.10 | |
50 | Neuropsychopharmacology | journal | 3.368 Q1 | 249 | 249 | 805 | 16794 | 5537 | 779 | 6.87 | 67.45 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®